Clinical trial
A Multicenter Study of the Efficacy of Cerezyme in Testing Skeletal Disease in…
NCT00365131 · Genzyme, a Sanofi Company, Industry · Completed
Key facts
| NCT number | NCT00365131 |
|---|---|
| Title | A Multicenter Study of the Efficacy of Cerezyme in Testing Skeletal Disease in Patients With Type I Gaucher Disease. |
| Lead sponsor | Genzyme, a Sanofi Company, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Gaucher Disease Type I, Cerebroside Lipidosis Syndrome, Clucocerebrosidase Deficiency Disease, Glucosylceramide Beta-Glucosidase Deficiency Disease, Gaucher Disease, Non-Neuronopathic Form |
| Intervention type | Drug |
| Interventions | Cerezyme (imiglucerase for injection) |
| Enrollment | 40 |
| Start date | Dec 1, 1997 |
| Completion | Jul 1, 2004 |
| First posted | Aug 17, 2006 |
| Last update posted | Mar 5, 2015 |
| Countries | United States |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: